第 1 到 6 筆結果,共 6 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2021 | Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models | CHIA YING LIEN ; Lu, Chen-Wen; Lin, Yi-Hsuan; Wu, Wan-Jhen; Hsu, Chih-Hsiang; TAI-YUAN CHUANG ; Lin, Kuei-Fu; Chuang, Wu-Chang; Lee, Ming-Chung; Wu, Chung-Hsin | Evidence-based complementary and alternative medicine : eCAM | 11 | 8 | |
2 | 2020 | 有氧運動訓練對高齡老化高脂飼養小鼠心臟結構與心肺功能之影響=The effects of aerobic exercise training on cardiac structure and cardiopulmonary function in aged and high fat diet mice | 黃以恆; 連家瑩 ; 方進隆; 莊泰源 | 運動與遊憩研究 | 0 | ||
3 | 2020 | Oral treatment with the Chinese herbal supplements B307 enhances muscle endurance of ICR mice after exhaustive swimming via suppressing fatigue, oxidative stress, and inflammation | Chuang, T.-Y.; Lien, C.-Y.; Tsai, Y.-C.; Lin, K.-F.; Hsu, C.-H.; Wu, W.-J.; Su, L.-Y.; Lu, C.-W.; Wu, C.-H.; CHIA YING LIEN ; TAI-YUAN CHUANG | Food Science and Nutrition | 5 | 4 | |
4 | 2020 | Chinese veterinary medicine B307 promotes cardiac performance and skeletal muscle contraction via enhancing intracellular calcium levels and neural electrical activity in animal and cell models | Lien, C.-Y.; Lu, C.-W.; Hsu, C.-H.; Chuang, T.-Y.; Su, L.-Y.; Wu, W.-J.; Jheng, Y.-S.; Lee, M.-C.; Wu, C.-H.; CHIA YING LIEN ; TAI-YUAN CHUANG | Evidence-based Complementary and Alternative Medicine | 3 | 2 | |
5 | 2020 | Chinese Herbal Medicine Alleviates Thyroidectomy-Induced Cardiopulmonary Exercise Dysfunction in Rats | Chuang, T.-Y.; Lien, C.-Y.; Hsu, C.-H.; Lu, C.-W.; Wu, C.-H.; CHIA YING LIEN ; TAI-YUAN CHUANG | Evidence-based Complementary and Alternative Medicine | 5 | 5 | |
6 | 2015 | Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis | Lien, C. Y. ; Chuang, T.Y. ; Hsu, C. H.; Lin, C. L.; Wang, S. E.; Sheu, S. J.; Chien, C. T.; Wu, C.H. | OncoTargets and Therapy | 13 | 12 |